XML 24 R13.htm IDEA: XBRL DOCUMENT

Income Taxes

12 Months Ended

Dec. 31, 2018

Income Tax Disclosure [Abstract]

NOTE 7 – INCOME TAXES

The components of loss before income taxes are as follows:

		2018				2017
Domestic			(2,468,805	)			(2,134,722	)
Foreign			(88,726	)			(124,914	)
Loss before income taxes			(2,557,531	)			(2,259,636	)

The Company had no income tax expense due to operating losses incurred for the years ended December 31, 2018 and 2017.

For the years ended December 31, 2018 and 2017, a reconciliation of the Company’s effective tax rate to the statutory U.S. Federal rate is as follows:

		2018				2017
Income taxes at Federal statutory rate			(21.0	)%			(34.0	)%
State income taxes, net of Federal income tax effect			(8.6	)%			(8.4	)%
Perm difference			0.0	%			0.0	)%
Foreign tax rate differential			(0.6	)%			(0.2	)%
Change in valuation allowance			30.2	%			42.6	%
Other			0.0	%			0.0	%
Income tax provision			0.0	%			0.0	%

The tax effects of temporary differences that give rise to the Company’s deferred tax assets and liabilities are as follows:

		2018				2017
U.S. net operating loss carryforwards			2,627,000				2,168,000
Stock compensation			359,000				472,000
Canadian Provincial income tax losses			56,000				123,000
Canadian Provincial scientific investment tax credits			-				-
			3,042,000				2,763,000
Valuation allowance			(3,042,000	)			(2,763,000	)
Net deferred tax assets			-				-

As of December 31, 2018 and 2017, the Company had federal net operating loss carryforwards (“NOL”) of approximately $6,617,000 and $5,287,000, respectively. The losses expire beginning in 2024. The Company has not performed a detailed analysis to determine whether an ownership change under IRC Section 382 has occurred. The effect of an ownership change would be the imposition of annual limitation on the use of NOL carryforwards attributable to periods before the change Any limitation may result in expiration of a portion of the NOL before utilization. As of December 31, 2018 and 2017, the Company had state and local net operating loss carryforwards of approximately $6,609,000 and $5,272,000, respectively, to reduce future state tax liabilities also through 2035.

As of December 31, 2018 and 2017, the Company had Canadian NOL of approximately $1,070,000 and $1,002,000, respectively. The Canadian losses expire in stages beginning in 2026. As of December 31, 2018 and 2017, the Company also has unclaimed Canadian federal scientific research and development investment tax credits, which are available to reduce future federal taxes payable of approximately $0 and $0 respectively.

As a result of losses and uncertainty of future profit, the net deferred tax asset has been fully reserved. The net change in the valuation allowance during the years ended December 31, 2018 and 2017 was an increase of $457,000 and $243,000, respectively.

Foreign earnings are assumed to be permanently reinvested. U.S. Federal income taxes have not been provided on undistributed earnings of our foreign subsidiary.

The Company recognizes interest and penalties related to uncertain tax positions in selling, general and administrative expenses. The Company has not identified any uncertain tax positions requiring a reserve as of December 31, 2018 and 2017.

The Company is required to file U.S. federal and state income tax returns. These returns are subject to audit by tax authorities beginning with the year ended December 31, 2014.